Valsartan |
Tablet |
|
|
Refer to USP |
|
|
2016/07/28 |
Vancomycin hydrochloride |
Capsule |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Vandetanib |
Tablet |
II (Paddle) |
50 |
pH 1.2 Buffer [0.05 M KCl in water, adjust the pH with HCl or NaOH] |
1000 |
5, 10, 15, 20 and 30 |
2015/06/25 |
Vardenafil HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Vardenafil HCl |
Tablet (Orally Disintegrating) |
II (Paddle) |
50 |
0.1 N HCl |
900 |
5, 10, 15 and 30 |
2014/05/15 |
Varenicline Tartrate |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Vemurafenib |
Tablet |
II (Paddle) |
75 |
1% hexadecyltrimethylammonium bromide (HTAB) in 0.05 M Phosphate Buffer, pH 6.8 |
900 |
10, 15, 20, 30 and 45 |
2015/05/28 |
Venetoclax |
Tablet |
III (Reciprocating Cylinder) [Bottom Screen: 200 mesh stainless steel] |
20 dpm |
Phosphate Buffer, pH 6.8 with 0.4% sodium dodecyl sulfate (SDS) [3 small drops of antifoaming agent may be used] |
250 |
0.25, 0.5, 0.75, 1, 1.5, 2, 3, 3.5 and 4 hours |
2016/07/28 |
Venlafaxine Besylate |
Tablet (Extended Release) |
II (Paddle with sinker) |
50 |
0.1 M NaCl in water (Degassed) |
900 |
1, 2, 4, 6, 8, 12, 14 and 16 hours |
2023/02/09 |
Venlafaxine HCl |
Tablet (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Venlafaxine HCl |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Venlafaxine HCl |
Capsule (Extended Release) |
|
|
Develop a dissolution method |
|
|
2023/09/15 |
Verapamil HCl |
Tablet |
|
|
Refer to USP |
|
|
2008/11/04 |
Verapamil HCl |
Capsule (Extended Release) |
|
|
Refer to USP |
|
|
2015/08/27 |
Verapamil HCl |
Tablet (Extended Release) |
|
|
Refer to USP |
|
|
2010/06/24 |
Vericiguat |
Tablet |
II (Paddle) |
75 |
0.01 N HCl, pH 2.0 |
900 |
5, 10, 15, 20 and 30 |
2022/07/07 |
Verteporfin |
Injectable |
|
|
Develop a method to characterize in vitro release. |
|
|
2014/08/14 |
Vibegron |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2023/02/09 |
Vigabatrin |
Tablet |
|
|
Refer to FDA's Dissolution Guidance, 2018 |
|
|
2020/07/02 |
Vilazodone HCl |
Tablet |
II (Paddle) |
60 |
0.1% v/v Glacial acetic acid solution (pH 3.1) |
1000 |
10, 15, 20, 30 and 45 |
2014/08/14 |